T. Jake Liang

Active 1990–2025

122
Papers
23,039
Citations
86
h-index
119
i10-index

Citations

Citations per year for T. Jake Liang1979: 2 citations1990: 3 citations1991: 16 citations1992: 19 citations1993: 21 citations1994: 24 citations1995: 16 citations1996: 33 citations1997: 24 citations1998: 26 citations1999: 62 citations2000: 59 citations2001: 88 citations2002: 88 citations2003: 117 citations2004: 124 citations2005: 135 citations2006: 209 citations2007: 235 citations2008: 205 citations2009: 200 citations2010: 209 citations2011: 178 citations2012: 189 citations2013: 214 citations2014: 268 citations2015: 206 citations2016: 227 citations2017: 175 citations2018: 175 citations2019: 609 citations2020: 658 citations2021: 600 citations2022: 393 citations2023: 243 citations2024: 380 citations2025: 157 citations2026: 2 citations1980–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,323 citing papers, 26.7% of this breakdownChina: 855 citing papers, 9.8% of this breakdownGermany: 642 citing papers, 7.4% of this breakdownFrance: 542 citing papers, 6.2% of this breakdownUnited Kingdom: 510 citing papers, 5.9% of this breakdownJapan: 375 citing papers, 4.3% of this breakdownItaly: 369 citing papers, 4.2% of this breakdownCanada: 268 citing papers, 3.1% of this breakdownAustralia: 205 citing papers, 2.4% of this breakdownTaiwan: 178 citing papers, 2% of this breakdownSpain: 175 citing papers, 2% of this breakdownIndia: 151 citing papers, 1.7% of this breakdown
0%26.7%Other 24.3%

Fields

  • Medicine75.6%
  • Biochemistry, Genetics and Molecular Biology13.2%
  • Immunology and Microbiology7.9%
  • Agricultural and Biological Sciences0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Computer Science0.4%
  • Other1.6%

Topics

  • Hepatitis C virus research16.1%
  • Hepatitis B Virus Studies13.8%
  • Liver Disease Diagnosis and Treatment8.7%
  • Hepatitis Viruses Studies and Epidemiology2.3%
  • Immune Cell Function and Interaction2.2%
  • HIV Research and Treatment1.8%
  • Other55.1%

Coauthors

All papers

Open in search
  1. A global scientific strategy to cure hepatitis B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William Mason, Gail Matthews, Dimitrios Paraskevis, Jörg Petersen, Barbara Rehermann, Eui‐Cheol Shin, Alexander Thompson, Florian van Bömmel, Fusheng Wang, Koichi Watashi, Hung‐Chih Yang, Zhenghong Yuan, Man‐Fung Yuen, Timothy M. Block, Veronica Miller, Ulrike Protzer, Christian Bréchot, Stephen Locarnini, Marion G. Peters, Raymond F. Schinazi, Fabien Zoulim - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 495

  2. Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions

    Authors: , - Gastroenterology 2017 cited by 588

  3. Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science 2014 cited by 877

  4. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 166

  5. Clinical trial: pilot study of metformin for the treatment of non‐alcoholic steatohepatitis

    Authors: , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2008 cited by 300

  6. A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer

    Authors: , , , , , , - Molecular Therapy — Oncolytics 2022 cited by 53

  7. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Behrooz Z. Alizadeh, Larry D. Atwood, Ingrid B. Borecki, Morris J Brown, Pimphen Charoen, Francesco Cucca, Debashish Das, Eco J. C. de Geus, Anna Dixon, Angela Döring, Georg Ehret, Guðmundur I. Eyjólfsson, Martin Farrall, Nita G. Forouhi, Nele Friedrich, Wolfram Goessling, Daníel F. Guðbjartsson, Tamara B. Harris, Anna‐Liisa Hartikainen, Simon Heath, Gideon M. Hirschfield, Albert Hofman, Georg Homuth, Elina Hyppönen, Harry L.A. Janssen, Toby Johnson, Antti J. Kangas, Ido P. Kema, Jens‐Peter Kühn, Sandra Lai, Mark Lathrop, Markus M. Lerch, Yun Li, T. Jake Liang, Jing‐Ping Lin, Ruth J. F. Loos, Nicholas G. Martin, Miriam F. Moffatt, Grant W. Montgomery, Patricia B. Munroe, Kiran Musunuru, Yusuke Nakamura, Christopher J. O’Donnell, Isleifur Olafsson, Brenda W.J.H. Penninx, Anneli Pouta, Bram P. Prins, Inga Prokopenko, Ralf Puls, Aimo Ruokonen, Markku J. Savolainen, David Schlessinger, Jeoffrey Schouten, Udo Seedorf, Srijita Sen‐Chowdhry, Katherine A. Siminovitch, Johannes H. Smit, Timothy D Spector, Wenting Tan, Tanya M. Teslovich, Taru Tukiainen, André G. Uitterlinden, Melanie M. van der Klauw, Ramachandran S. Vasan, Chris Wallace, Henri Wallaschofski, H‐Erich Wichmann, Gonneke Willemsen, Peter Würtz, Chun Xu and 37 more - Nature Genetics 2011 cited by 595

  8. Molecular bases of strawberry fruit quality traits: Advances, challenges, and opportunities

    Authors: , , - PLANT PHYSIOLOGY 2023 cited by 65

  9. Hepatitis B Virus–Specific and Global T-Cell Dysfunction in Chronic Hepatitis B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Colina Yim, Jenny Heathcote, Robert Perrillo, Son Do, Steven‐Huy B. Han, Tram T. Tran, Stewart Cooper, Robert J. Fontana, Naoky Tsai, Michael Fried, Keyur Patel, Donna M. Evon, Margaret C. Shuhart, Chia C. Wang, Marc G. Ghany, T. Jake Liang, Steven H. Belle, Yona Keich Cloonan, David E. Kleiner - Gastroenterology 2015 cited by 258

  10. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

    Authors: , , , , , , , , , , , - Nature Medicine 2005 cited by 2,729

  11. Direct, Interferon-Independent Activation of the CXCL10 Promoter by NF-κB and Interferon Regulatory Factor 3 during Hepatitis C Virus Infection

    Authors: , , , , , , , - Journal of Virology 2013 cited by 131

  12. Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages

    Authors: , , , , , , , - Hepatology 2017 cited by 167

  13. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions

    Authors: , , , , , , , - Journal of Hepatology 2016 cited by 140

  14. Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation

    Authors: , , , , , , , - Gastroenterology 2017 cited by 116

  15. Modeling PNPLA3‐Associated NAFLD Using Human‐Induced Pluripotent Stem Cells

    Authors: , , , , , , , , - Hepatology 2021 cited by 77

  16. Present and future therapies of hepatitis B: From discovery to cure

    Authors: , , , , , , , , , - Hepatology 2015 cited by 318

  17. Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection

    Authors: , , , , , , , , , , - Gastroenterology 2011 cited by 310

  18. Hepatitis B virus–induced lipid alterations contribute to natural killer T cell–dependent protective immunity

    Authors: , , , , , , , , , , , , , , , , , , - Nature Medicine 2012 cited by 222

  19. The Application and Mechanism of Action of Ribavirin in Therapy of Hepatitis C

    Authors: , , - Antiviral chemistry & chemotherapy 2012 cited by 154

  20. Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection

    Authors: , - Gastroenterology 2018 cited by 127

  21. A Viral Exposure Signature Defines Early Onset of Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell 2020 cited by 86

  22. SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype

    Authors: , , , , , , , , , , - Communications Biology 2023 cited by 42

  23. Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy

    Authors: , , , , , , - Annals of Internal Medicine 2008 cited by 460

  24. Long-term therapy of chronic delta hepatitis with peginterferon alfa

    Authors: , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2014 cited by 117